Blog

Blog2018-08-07T09:20:06+00:00

Latest Posts

Latest posts from the field of manufacturing biological macromolecules.

  • Jafral, manufacturing biological macromolecules 003

WHO: World is running out of antibiotics

On 20th September 2017, WHO launched report about antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis. Report shows a

  • Jafral, manufacturing biological macromolecules 008

A patient’s legacy: Researchers work to make

Because there have not been rigorous clinical trials of phages, they can be used only on patients for whom all other options have failed.

  • Jafral, manufacturing biological macromolecules 007

EU Antibiotic resistance day

Combined resistance to multiple antibiotics: a growing problem in the EU On the occasion of the 10th European Antibiotic Awareness Day, the European Centre for Disease [...]

  • Jafral, manufacturing biological macromolecules 004

First cancer gene therapy to treat leukaemia approved by

US regulators on Wednesday approved the first gene therapy against cancer - a treatment that uses a patient's own immune cells to fight leukemia - opening a new era in the fight against one of the

  • Jafral, manufacturing biological macromolecules 001

Phage Therapy Saves Patient with Multidrug-Resistant

Scientists and physicians at University of California San Diego School of Medicine in collaboration with colleagues at the U.S. Navy Medical Research Center – Biological Defense Research Directorate

  • Jafral, manufacturing biological macromolecules

First gene therapy product could enter market in Q1 2018

First gene therapy product could enter market in Q1 2018 The U.S. FDA has approved an application for a gene therapy for blindness. The proposed gene [...]

Load More Posts

Discover The Future

Our preferred approach is to work side by side with our customers from a very early stage

Contact Us